YARA BUY TP: NOK430. CMD preview to raise or not to raise

Size: px
Start display at page:

Download "YARA BUY TP: NOK430. CMD preview to raise or not to raise"

Transcription

1 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Materials Company update This report was completed and disseminated at 17:18 CET on 0 YARA CMD preview to raise or not to raise Ahead of Yara s Q4 results and CMD, 52% of respondents to our buy-side survey said they expect Yara to increase the improvement target at the CMD; the median expectation is a 2020 target of USD625m. We are confident Yara will raise the target, but not necessarily at the CMD. We are bullish on urea in Q1 given India s inventory position and China s supply restrictions, and keep our BUY recommendation and NOK430 target price. CMD to raise or not to raise. According to our buy-side survey, expectations are not particularly high ahead of Yara s Q4 results and CMD on 8 February % of respondents believe Yara will raise the improvement target at the CMD; the median expectation is an increase to USD625m in 2020, versus the current USD500m target. We also believe Yara will raise the improvement target, but not necessarily at the CMD, as the programme has not yet been rolled-out to several important plants. We factor in USD350m in improvements in 2018 (versus the USD300m target), but still USD500m in 2020, in line with its target. Q4 preview finally set for earnings growth. For the first time in more than two years we forecast positive EBITDA growth, to NOK3.2bn (excluding one-offs), up 32% YOY. This is in line with consensus, and driven by positive price/margin, which we expect to rise by] NOK1.2bn YOY due to higher urea and nitrate prices. We see this being partially offset by higher gas costs and a stronger NOK. We expect Yara to have reached USD240m in cumulative savings by end-q4 2017, compared to the USD150m target. We are NOK1 above consensus on the DPS for 2017e at NOK10, as we believe no share buybacks and strong future FCF warrant a slightly higher payout ratio. BUY on strong urea momentum and CMD update. We are bullish urea given India s inventory position and China s supply restrictions, potentially leaving the two markets competing for product in Q1 for the first time since the mid-1990s. As we also expect positive comments at the CMD we reiterate our BUY recommendation on Yara. Our target price remains NOK430, as we have made limited net estimate changes ahead of Q4, with gas costs increases offset by higher DAP upgrading margins. Year-end Dec e 2018e 2019e 2020e Revenue (NOKm) 95, ,011 95,245 93,605 99, , ,068 EBITDA adj (NOKm) 16,544 18,919 14,450 12,198 17,265 19,569 22,929 EBIT adj (NOKm) 11,641 14,434 9,136 5,726 10,542 12,307 14,937 PTP (NOKm) 9,808 13,127 9,463 5,314 9,548 11,205 13,835 EPS rep (NOK) EPS adj (NOK) DPS (NOK) Revenue growth (%) EBITDA growth adj (%) EPS growth adj (%) EBITDA margin adj (%) EV/Sales adj (x) EV/EBITDA adj (x) EV/EBIT adj (x) P/E adj (x) P/Book (x) ROE (%) ROCE (%) Dividend yield (%) BUY TP: NOK430 YAR versus OSEBX (12m) Jan Mar May Jul Sep Nov Jan Yara OSEBX (Rebased) Source: Factset SUMMARY Recommendation (prev.) BUY (BUY) Share price (NOK) 397 Target price (previous) (NOK) 430 (430) Upside/downside potential (%) 8 Tickers YAR NO, YAR.OL CAPITAL STRUCTURE No. of shares (m) No. of shares fully dil. (m) Market cap. (NOKm) 109,225 NIBD adj end-2017e (NOKm) 25,334 Enterprise value adj (NOKm) 134,558 Net debt/ebitda adj (x) 2.08 SHARE PRICE PERFORMANCE Abs. 1/3/12m (%) 8/11/13 Rel. 1/3/12m (%) 2/5/-8 High/Low 12m (NOK) 397/301 Free float (%) 57 Source: Company, DNB Markets (estimates) NEXT EVENT Q4 17/ CMD 08/02/2018 ESTIMATE CHANGES (NOK) Year-end Dec 2017e 2018e 2019e EPS (old) EPS (new) Change (%) Consensus Sales (old) 93,525 99, ,824 Sales (new) 93,605 99, ,814 Change (%) Consensus 95, , ,398 Source: DNB Markets, Bloomberg ANALYSTS Eivind Sars Veddeng Eivind.Sars.Veddeng@dnb.no Please see the last two pages for important information. This research report was not produced in the US. Analysts employed by non-us affiliates are not registered/ qualified research analysts with FINRA in the United States.

2 2016 Revenues Costs Other 2017e Revenues Costs Other 2018e DNB Markets Yara Investment case overview Share price performance, DNB Markets target price, bear- and bull-case scenarios 580 NOK550 (39%) NOK397 NOK430 (8%) 330 NOK300 (-24%) 280 Jan 2017 May 2017 Sep 2017 Jan 2018 May 2018 Sep 2018 Jan 2019 Historical Share Price Performance Price Target (Jan 19) Current Share Price Target price methodology We continue to base our target price on the present value of 2020e earnings using the historical average 7x EV/EBITDA (unchanged). In our view the shares do not reflect improved market fundamentals or the solid progress in Yara s improvement programme. Our DCF is NOK570/share. Our bull- and bear-case fair values assume urea prices of USD300/mt and USD200/mt, respectively, on the same EV/EBITDA multiple approach. Source: FactSet, DNB Markets Source: DNB Markets Downside risks to our investment case China and India over-apply nitrogen; more rational application could mean downside to demand. Coal is the prime input for marginal producers, so lower coal prices (we assume flat) could cut cash costs further. As European gas prices are Yara s most important input, higher gas prices could mean downside risk. Removal of trade barriers could increase supply of AN (e.g. Russia). DNB Markets investment case and how we differ from consensus We are 10% ahead of consensus on 2018e EBITDA as it does not seem to reflect the strong performance of the improvement programme. Consensus urea and nitrate price assumptions also look too low given higher coal prices, lower Chinese exports, and lower nitrate inventories. We assume a 12% EBITDA CAGR for e. We believe the improvement targets could be raised already in Upside risks to our investment case Many Chinese urea plants operate at a loss; a rational approach would be to shut capacity and reduce exports, leaving the market more balanced. A 10% weakening of the NOK versus the USD would raise our annual EPS by cnok6.7. New project announcements or acquisitions could drive up the share price. More than USD500m of improvements from the current programme. Source: DNB Markets Source: DNB Markets Source: DNB Markets Sustainable EPS bridge e (NOKm) Source: DNB Markets (forecasts), company (historical data) 2

3 CMD to raise or not to raise 52% of investors surveyed expect improvement targets to be raised Ahead of the Q4 results and CMD on 8 February 2018 we surveyed 23 investors to get a better understanding of buy-side expectations on Yara s improvement programme targets. 52% believe Yara will raise the target at the CMD; the median expectation is a target of USD625m in 2020e versus the current USD500m target. We also believe Yara will raise the improvement target, but not necessarily at the CMD as the programme has not yet been rolled-out to several important plants. We factor in USD350m in improvements in 2018e (versus the USD300m target), but still USD500m in 2020e, in line with its target. Figure 1: Survey results Keep current target, 13% Raise target at a later stage, 13% 50/50, 22% Rase target at CMD, 52% Source: DNB Markets Survey results: We received 23 responses, of which 65% were from Norwegian investors. 52% of respondents believe Yara will raise the target at the CMD on 8 February. 13% think it will be raised at a later stage, while 13% believe it will keep its current target. The remaining 22% believe it is 50/50 whether it raises the target. The median expectation is for Yara to raise its improvement target to USD625m in 2020e versus the current USD500m target. In our sample, local investors were more positive than the internationals (mostly UK), with median target expectations of USD650m and USD513m, respectively. The highest target expectation was USD750m, both in locally and internationally Figure 2: Survey results (USDm) Source: DNB Markets High Domestic Median Median Average London Median Low 3

4 Our take: In our Yara estimates, we have not factored in an increase in the USD500m improvement target, but given the strong feedback from the plants (please see our comments from our Sluiskil site visit in our report published on 13 December 2017), and the strong initial results from the programme (see figure 4 below), we believe management could very well raise the targets. The arguments against an increase are that the programme has not yet been rolled out in all plants, and that Yara does not want to over-promise and under-deliver. The programme has not yet been implemented at sites like Porsgrunn, Glomfjord, Køping or Galvani, and before it is, management may not be comfortable with raising the bar yet, but that an upgrade is likely at a later stage. As the programme is running 40% ahead of schedule, we have factored in improvements of USD350m (current target USD300m) by end We still expect the CMD to be a positive event as it will most likely contain bullish comments on further savings potential Figure 3: Yara improvement programme (USDm) Figure 4: Improvement programme target (USDm) e 2018e 2019e 2020e 0 Q4 Q1 Q2 Q3 Q4e Yara targets in 2015 prices DNBe in 2015 prices Program annualized in 2015 price Program in 2017 prices DNBe estimated P&L effect DNB estimate in 2017 running prices Source: Company (targets), DNB Markets (Further calculations, estimates) Source: Company (historical figures), DNB Markets (Further calculations, estimates) The aim was to roll out the improvement programme to 50% of the 27 sites by end- 2017However, it had only been fully rolled-out to seven sites at that date, but according to the company it had identified potential improvements far exceeding initial expectations, predominantly in higher production volumes. Five out of those seven plants set 12-month rolling production records in September or October Further, several monthly production records were set in November Figure 5: Roll-out schedule Sites Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Slusikil Pilbara Porsgrunn Large Uusikaupunki Rio Grande Galvani, Salitre (Luis E, Angico) Belle Plane Trinidad & Tringen I and II QAFCO Small and Medium Rostock Tertre Brünsbuttel Ferrara Ravenna Ambes Le Havre Montoir Glomfjord Köping Source: Company Sillinjärvi Kokkola SVI Mining Pontagrossa Cartagena 4

5 DNB Markets Yara Figure 6: Production volumes Source: Company Q4 preview finally set for earnings growth For the first time in more than two years we forecast positive EBITDA growth, to NOK3.2bn (excluding one-offs), up 32% YOY. This is in line with consensus, and driven by positive price/margin, which we expect to rise by NOK1.2bn YOY due to higher urea and nitrate prices. We see this being partially offset by higher gas costs and a stronger NOK. We expect Yara to have reached USD240m in cumulative savings by end-q4 2017, compared to the USD150m target. We are NOK1 above consensus on the DPS for 2017e at NOK10, as we believe no share buybacks and strong future FCF warrant a slightly higher payout ratio. Figure 7: Urea and nitrates (USD/mt) CAN CIF Germany Urea granular FOB Egypt Source: Profercy Figure 8: EU Natgas (USD/mmbtu) Day ahead EU Natgas Source: Bloomberg (underlying data), DNB Markets (further calculations) 5

6 Figure 9: YOY EBITDA bridge 3,800 3,600 3,400 3,200 3,000 2,800 2,600 2,400 2,200 2,000 2,474 3,262 3,204 Source: DNB Markets (forecasts), company (historical data), Bloomberg (consensus) Figure 10: EBITDA (NOKm) 7,000 6,000 5,000 4,000 3,000 2,000 1, % 80% 60% 40% 20% 0% -20% -40% -60% EBITDA ex special items YoY, rhs Source: ads 6

7 Figure 11: Q4 preview Q4 2017e DNB vs. Cons. Q4 16 DNBe NOKm, NOK per share DNB Cons. Abs. % Actual 2017e Revenues 23,857 24, % 22,169 93,605 Raw Materials, energy costs etc -17,495-16,650-70,096 SG&A and other -3,569-3,469-12,867 Share of net income in EAI's Interest and other financial income EBITDA (Yara definition) 3,262 3, % 2,015 11,856 Non recurring effects in Yara EBITDA EBITDA ex one offs (Yara def.) 3,262 3, % 2,474 12,198 Depreciation,Amortisation and impairments -1,476-1,492-1% -1,687-6,130 EBIT ex one offs (Yara def.) 1,786 1, % 342 5,726 Net income 1,234 1, % ,336 Net profit adjusted 1,234 1, % 192 4,114 EPS reported Sustainable EPS % DPS % 10.0 Market data USDNOK EURNOK Urea Price Yuzhnyy (USD/Mt) Yara realised Nitrate price (USD/mt) Realised Nitrate Premium (USD/Mt) TTF (USD/Mmbtu) Yara Europe gas cost (USD/Mmbtu) Own production (k tons) Ammonia 1,900 1,885 7,386 Urea 1,336 1,326 5,235 Nitrates 1,594 1,554 6,151 NPK (ex blends) 1,329 1,226 5,470 NPK - blends (sales) 1,397 1,330 4,921 Source: DNB Markets (forecasts), company (historical data), Bloomberg (consensus) BUY on strong urea momentum and CMD update We are bullish urea given India s inventory position and China s supply restrictions, potentially leaving the two markets competing for product in Q1 for the first time since the mid-1990s. As we also expect positive comments at the CMD we reiterate our BUY recommendation on Yara. Our target price remains NOK430, as we have made limited net estimate changes ahead of Q4. Our target price is based on 16x 2018e earnings, justified by a 2020e ROCE of 13% (similar ROE) and a e EBITDA CAGR of 12%. We also believe the shares could re-rate as earnings growth is based on endogenous improvements and not exogenous price variables. Figure 12: Target price 2020e EBITDA (NOKm) 22,929 Fair multiple 7x NIBD + min (NOKm) 19, e FCF (NOKm) 12,243 Fair value 149,070 Per share 546 Current value e EV/EBITDA (x) e P/E (x) 16.1 P/B (x) 1.5 Shares (m) 273 ROE 12% Source: DNB Markets 7

8 Figure 13: Peer 2018e P/E (x) Source: Bloomberg (underlying data), DNB Markets (further calculations) Figure 14: Historical EV/EBITDA (x) Source: Bloomberg (underlying data), DNB Markets (further calculations) EV/EBITDA (7.9x) Average (6.9x) DNBe Figure 15: P/E (x) P/E (16.6x) Average (10.6x) DNBe Source: Bloomberg (underlying data), DNB Markets (further calculations) 8

9 Forecast changes P&L New Old Change (NOKm) 2017e 2018e 2019e 2017e 2018e 2019e 2017e 2018e 2019e Revenues 93,605 99, ,814 93,525 99, , Operating expenses -82,265-83,093-82,865-82,297-82,770-82, EBITDA 11,856 17,265 19,569 11,734 17,256 19, EBITDA adj 12,198 17,265 19,569 12,076 17,256 19, EBITDA margin (%) Depreciation -6,130-6,724-7,261-6,004-6,735-7, EBIT 5,726 10,542 12,307 5,731 10,520 12, EBIT adj 5,726 10,542 12,307 5,731 10,520 12, Net interest FX gains Net financial items Non-recurring items PBT 5,314 9,548 11,205 5,319 9,527 11, Taxes -1,372-2,319-2,738-1,375-2,318-2, Minorities Discontinued operations Net profit 3,994 7,281 8,519 3,996 7,261 9, Adjustments to net profit Net profit adj 4,024 7,281 8,519 4,026 7,261 8, Per share data (NOK) EPS EPS adj DPS ordinary DPS Other key metrics (%) Revenue growth EBIT adj growth EPS adj growth Avg. number of shares (m) Capex -16,766-10,900-7,500-16,766-10,900-7, Working capital 16,002 16,381 16,481 15,949 16,267 16, NIBD adj 25,334 25,340 20,712 25,438 24,974 20, Source: DNB Markets Forecast changes By segment and assumptions New Old Change (NOKm) 2017e 2018e 2019e 2017e 2018e 2019e 2017e 2018e 2019e Assumptions USDNOK Urea CAN Urea 5,235 6,653 6,700 5,235 6,653 6, Nitrate 6,151 6,576 6,646 6,151 6,576 6, NPK(compound) 5,470 5,840 5,887 5,390 5,840 5, Source: DNB Markets 9

10 Quarterly numbers (NOKm) Q Q Q Q Q Q Q4 2017e Q1 2018e Q2 2018e Q3 2018e Q4 2018e Revenues 24,310 23,864 22,169 22,743 23,345 23,660 23,857 24,420 24,787 25,675 24,837 Operating expenses -20,460-20,848-19,954-19,497-20,537-21,379-20,852-19,713-20,828-21,580-20,972 EBITDA 5,488 3,005 2,015 3,217 2,991 2,386 3,262 4,762 4,142 4,246 4,115 Depreciation -1,715-1,563-1,687-1,443-1,665-1,546-1,476-1,681-1,681-1,681-1,681 EBIT 3,773 1, ,774 1, ,786 3,081 2,461 2,566 2,434 Net interest FX gains Net financial items Non-recurring items 1, PBT 5,169 1, ,068 1, ,617 2,849 2,229 2,312 2,159 Taxes Minorities Discontinued operations 1, , ,234 2,187 1,703 1,753 1,639 Net profit 6,287 1, ,944 1,610 1,244 2,469 4,374 3,406 3,505 3,278 Adjustments to net profit -4, , ,234-2,187-1,703-1,753-1,639 Net profit adj 1, , ,234 2,187 1,703 1,753 1,639 Dividend paid -3, , , Avg. number of shares (m) Per share data (NOK) EPS EPS adj Growth and margins (%) Revenues, QOQ growth Revenues, YOY growth EPS adj, YOY growth Gross margin nm nm nm nm nm nm nm nm nm nm nm EBITDA adj margin Depreciation/revenues EBIT adj margin nm nm nm nm nm nm nm nm nm nm nm Net profit margin nm Adjustments to quarterly numbers (NOKm) Q Q Q Q Q Q Q4 2017e Q1 2018e Q2 2018e Q3 2018e Q4 2018e EBITDA 5,488 3,005 2,015 3,217 2,991 2,386 3,262 4,762 4,142 4,246 4,115 Gains and losses -1, Other EBITDA adjustments 1, EBITDA adj 3,958 2,968 2,474 3,335 2,873 2,728 3,262 4,762 4,142 4,246 4,115 Gains and losses -1, EBIT 3,773 1, ,774 1, ,786 3,081 2,461 2,566 2,434 Gains and losses -1, Net profit 6,287 1, ,944 1,610 1,244 2,469 4,374 3,406 3,505 3,278 Gains and losses -1, Other adjustments -4, , ,234-2,187-1,703-1,753-1,639 Net profit adj 1, , ,234 2,187 1,703 1,753 1,639 10

11 Annual P&L (NOKm) e 2018e 2019e 2020e Revenues 77,725 83,997 84,668 95, ,011 95,245 93,605 99, , ,068 Operating expenses -64,127-69,520-72,774-79,809-90,220-81,261-82,265-83,093-82,865-82,824 EBITDA 18,113 16,952 13,394 16,318 21,366 15,562 11,856 17,265 19,569 22,929 Depreciation -2,677-3,423-3,744-4,677-6,932-6,426-6,130-6,724-7,261-7,992 EBIT 15,436 13,529 9,650 11,641 14,434 9,136 5,726 10,542 12,307 14,937 Net interest FX gains , Net financial items ,439-1,057-3, Non-recurring items 2, ,447 1, PBT 16,505 13,285 7,357 9,808 13,127 9,463 5,314 9,548 11,205 13,835 Taxes -2,315-2,583-1,603-2,092-2,209-2,040-1,372-2,319-2,738-3,397 Effective tax rate (%) Minorities Discontinued operations Net profit 14,167 10,653 5,405 7,398 10,566 7,391 3,994 7,281 8,519 10,490 Adjustments to net profit -3, ,725 1,099-1,940-2, Net profit adj 10,566 9,877 7,129 8,497 8,626 5,312 4,024 7,281 8,519 10,490 Dividend paid -1,584-1,998-3,647-2,770-3,581-4,108-2,732-2,732-3,552-4,372 Avg. number of shares Per share data (NOK) EPS EPS adj DPS ordinary DPS Growth and margins (%) Revenue growth EPS adj growth Gross margin nm nm nm nm nm nm nm nm nm nm EBITDA margin EBITDA adj margin Depreciation/revenues EBIT margin EBIT adj margin PBT margin Net profit margin

12 Adjustments to annual P&L (NOKm) e 2018e 2019e 2020e EBITDA 18,113 16,952 13,394 16,318 21,366 15,562 11,856 17,265 19,569 22,929 Gains and losses -4,516-2,475-1,500-1,081-3,575-1, Other EBITDA adjustments 2, ,447 1, EBITDA adj 16,010 16,850 13,834 16,544 18,919 14,450 12,198 17,265 19,569 22,929 Gains and losses -4,516-2,475-1,500-1,081-3,575-1, EBIT 15,436 13,529 9,650 11,641 14,434 9,136 5,726 10,542 12,307 14,937 Gains and losses -4,516-2,475-1,500-1,081-3,575-1, EBIT adj 15,436 13,529 9,650 11,641 14,434 9,136 5,726 10,542 12,307 14,937 Net profit 14,167 10,653 5,405 7,398 10,566 7,391 3,994 7,281 8,519 10,490 Gains and losses -4,516-2,475-1,500-1,081-3,575-1, Other adjustments -3, ,725 1,099-1,940-2, Net profit adj 10,566 9,877 7,129 8,497 8,626 5,312 4,024 7,281 8,519 10,490 Per share data (NOK) EPS Recommended adjustment EPS adj Cash flow (NOKm) e 2018e 2019e 2020e Net profit 14,167 10,653 5,405 7,398 10,566 7,391 3,994 7,281 8,519 10,490 Change in net working capital -4,990 1,629 2,187-3,827-1,465 4,266-2, Cash flow from operations (CFO) 7,364 13,234 12,304 8,606 14,631 14,083 5,878 13,627 15,680 18,228 Capital expenditure 431-3,956-9,513-9,697-6,889-10,603-16,766-10,900-7,500-7,000 Cash flow from investing (CFI) 431-3,956-9,513-9,697-6,889-10,603-16,766-10,900-7,500-7,000 Net change in debt -2,371-1,792-1, ,460 1,138 11,073 5, Dividends paid -1,584-1,998-3,647-2,770-3,581-4,108-2,732-2,732-3,552-4,372 Other , Cash flow from financing (CFF) -4,873-5,205-5,908-2,142-8,113-2,949 8,306 2,268-3,552-4,372 Total cash flow (CFO+CFI+CFF) 2,922 4,073-3,117-3, ,582 4,994 4,628 6,857 FCFF calculation Less: net interest Growth (%) CFO CFI FCF nm nm nm nm nm nm nm nm nm nm CFF FCFF nm nm nm nm nm nm nm nm nm nm 12

13 Balance sheet (NOKm) e 2018e 2019e 2020e Assets 73,900 81,250 88, , , , , , , ,779 Inventories 12,683 11,927 13,129 18,639 19,948 17,580 20,245 20,797 21,000 21,402 Trade receivables 8,680 8,045 9,339 12,100 12,098 10,332 11,651 12,126 12,408 12,817 Current financial assets 2,947 2,618 3,386 4,243 5,916 4,905 4,773 4,773 4,773 4,773 Cash and cash equivalents 5,868 9,941 6,824 3,591 3,220 3,751 1,169 6,163 10,791 17,648 Current assets 30,177 32,531 32,678 38,573 41,182 36,568 37,838 43,859 48,972 56,640 Property, plant and equipment 24,118 27,893 34,611 44,584 52,424 59,739 69,103 73,721 74,519 74,255 Goodwill 5,164 7,512 8,419 12,008 9,583 9,183 8,835 8,393 7,834 7,106 Investments in associates 11,092 10,509 9,361 10,926 9,769 9,190 8,601 8,601 8,601 8,601 Defferred tax assets 1,474 1,376 1,984 2,804 2,950 2,585 2,907 2,907 2,907 2,907 Non-current financial assets 1,875 1,429 1,549 2,737 2,956 3,240 3,270 3,270 3,270 3,270 Non-current assets 43,723 48,719 55,924 73,059 77,682 83,937 92,716 96,892 97,131 96,139 Total assets 73,900 81,250 88, , , , , , , ,779 Equity and liabilities 73,900 81,250 88, , , , , , , ,779 Total equity to the parent 44,622 48,246 53,621 63,765 73,890 74,444 73,778 78,328 83,294 89,412 Minority interests 157 1,745 2,152 4,196 1,837 2,326 2,197 2,197 2,197 2,197 Total equity 44,779 49,991 55,773 67,961 75,727 76,770 75,975 80,525 85,491 91,609 Trade payables 8,523 9,665 11,961 14,628 14,674 14,762 15,894 16,542 16,927 17,484 Other payables and accruals 3,341 4,209 6,837 6,697 7,409 3,942 5,439 5,439 5,439 5,439 Short-term debt Total current liabilities 12,194 14,115 19,267 21,684 22,419 19,038 21,957 22,605 22,990 23,547 Long-term debt 10,280 9,287 5,833 10,609 9,354 13,992 22,038 27,038 27,038 27,038 Deferred tax liabilities 3,489 4,442 4,423 5,767 5,392 4,396 4,739 4,739 4,739 4,739 Pension liabilities Other non-current liabilities 2,907 3,008 2,908 4,886 5,199 5,475 5,006 5,006 5,006 5,006 Total non-current liabilities 16,928 17,144 13,562 21,987 20,718 24,697 32,622 37,622 37,622 37,622 Total liabilities 29,121 31,259 32,829 43,671 43,137 43,735 54,579 60,227 60,612 61,169 Total equity and liabilities 73,900 81,250 88, , , , , , , ,779 Key metrics Net interest bearing debt 2,603-1, ,823 11,871 12,805 25,334 25,340 20,712 13,855 Invested capital 56,562 59,026 66,431 89,170 95,054 97, , , , ,873 13

14 Valuation ratios (NOKm) e 2018e 2019e 2020e Enterprise value Share price (NOK) Number of shares (m) Market capitalisation 68,959 77,326 72,730 92, ,345 92, , , , ,468 Net interest bearing debt 2,603-1, ,823 11,871 12,805 25,334 25,340 20,712 13,855 Adjustments to NIBD Net interest bearing debt adj 2,603-1, ,823 11,871 12,805 25,334 25,340 20,712 13,855 EV 71,562 75,673 72, , , , , , , ,323 EV adj 71,562 75,673 72, , , , , , , ,323 Valuation EPS EPS adj DPS ordinary DPS P/E P/E adj P/B Average ROE 35.4% 22.5% 10.2% 12.0% 14.7% 9.7% 5.2% 9.3% 10.3% 11.8% Earnings yield adj 14.6% 12.9% 9.5% 9.2% 8.2% 5.7% 4.2% 6.7% 7.9% 9.7% Dividend yield 2.9% 4.7% 3.8% 3.9% 3.9% 2.9% 2.7% 3.3% 4.0% 4.8% EV/SALES EV/SALES adj EV/EBITDA EV/EBITDA adj EV/EBIT EV/EBIT adj EV/capital employed Key accounting ratios e 2018e 2019e 2020e Profitability (%) ROA ROCE Return on invested capital (%) Net PPE/revenues Working capital/revenues Revenues/invested capital (pre-gw) Cash flow ratios (%) CFO/revenues CFO/market capitalisation CFO/capex CFO/current liabilities Capex/revenues Capex/depreciation Total payout ratio Leverage and solvency (x) Interest cover EBIT/interest payable Cash coverage Net debt/ebitda Total debt/total capital (BV) LTD / (LTD + equity (MV))

15 15

16 Important Information Company: Yara Coverage by Analyst: Eivind Sars Veddeng Date: 09/1/2018 This report has been prepared by DNB Markets, a division of DNB Bank ASA. DNB Bank ASA is a part of the DNB Group. This report is based on information obtained from public sources that DNB Markets believes to be reliable but which DNB Markets has not independently verified, and DNB Markets makes no guarantee, representation or warranty as to its accuracy or completeness. This report does not, and does not attempt to, contain everything material which there is to be said about the Company. Any opinions expressed herein reflect DNB Markets judgement at the time the report was prepared and are subject to change without notice. The report is planned updated minimum every quarter. Any use of non-dnb logos in this report is solely for the purpose of assisting in identifying the relevant issuer. DNB is not affiliated with any such issuer. This Report is for clients only, and not for publication, and has been prepared for information purposes only by DNB Markets, a division of DNB Bank ASA. This research report is the property of DNB Markets. DNB Markets retains all intellectual property rights (including, but not limited to, copyright) relating to the research report. Sell-side investment firms are not allowed any commercial use (including, but not limited to, reproduction and redistribution) of the research report contents, either partially or in full, without DNB Markets explicit and prior written consent. However, buy-side investment firms may use the research when making investment decisions, and may also base investment advice given to clients on the research. Such use is dependent on the buy-side investment firm citing DNB Markets as the source. Recommendation structure and risk classification DNB Markets recommendations are based on absolute performance: Buy Hold Sell - indicates an expected return greater than 10% within 12 months - indicates an expected return between 0 and 10% within 12 months - indicates an expected negative return within 12 months The return-requirement bands above may be applied with some degree of flexibility depending on the liquidity and volatility characteristics of the individual share. High risk Medium risk Low risk - Volatility over 40 percent. - Volatility from 25 percent to 40 percent. - Volatility under 25 percent. Current 6 months volatility rates this security as LOW risk. Investing in any security is subject to substantial risk. Return on investment may vary greatly. Careful consideration for possible financial distress should be accounted for before investing in any security. Price targets are based on a combination of several valuation methods such as discounted cash flow, pricing based on earnings multiples, multiple on book value, net asset value and peer comparison. Substantial material sources for coverage of this company include historical financial figures and communication with the company, and relevant third party information. Recommendations and historical target prices below may not compile all recommendations by DNB Markets, for further information please contact DNB Markets. Price, Rating, and Price Target History Yara (YAR NO) as of S : H : H : B : Source: Factset Estimates (Prices) / DNB (ratings and target price) Conflict of interest DNB Markets has provided investment services and/or ancillary services to the company and received compensation for it during the past 12 months. DNB Markets has been lead or co-lead manager related to an Investment Banking assignment for the company and received compensation for it during the past 12 months. Readers should assume that DNB Markets may currently or may in the coming three months and beyond be providing or seeking to provide confidential investment banking services or other services to the company/companies Share positions in the company: Analyst* Employees** DNB*** Update Number of shares /01/2018 *The analyst or any close associates. **Share positions include people involved in the production of credit and equity research, including people that could reasonably be expected to have access to it before distribution. ***Share positions as part of DNB Group. Holdings as part of DNB Markets investment services activity are not included. Recommendation distribution and corporate clients for the last 12 months Buy Hold Sell No_rec Total Number % of total 49% 31% 15% 5% DNB Markets client 23% 11% 4% 4% 94 16

17 Legal statement These materials constitute research as defined in section 9-27 (1) of the Norwegian Securities Trading Regulations (Norwegian: verdipapirforskriften), and are not investment advice as defined in section 2-4(1) of the Norwegian securities trading act (Norwegian verdipapirhandelloven). The analyst hereby certifies that (i) the views expressed in this report accurately reflect that research analyst s personal views about the company and the securities that are the subject of this report, and (ii) no part of the research analyst s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in this report. DNB Markets employees, including research analysts, may receive compensation that is generated by overall firm profitability. Confidentiality rules and internal rules restricting the exchange of information between different parts of DNB Markets/DNB Bank ASA or the DNB Group are in place to prevent employees of DNB Markets who are preparing this report from utilizing or being aware of information available in the DNB Group that may be relevant to the recipients decisions. DNB Markets and the DNB Group have incorporated internal rules and regulations in order to avoid any potential conflicts of interest. The Report has been prepared by DNB Markets, a division of DNB Bank ASA, a Norwegian bank organized under the laws of the Kingdom of Norway and under supervision by the Norwegian Financial Supervisory Authority, The Monetary Authority of Singapore, and on a limited basis by the Financial Conduct Authority and the Prudential Regulation Authority of the UK, and the Financial Supervisory Authority of Sweden. Details about the extent of our regulation by local authorities outside Norway are available from us on request. It is issued subject to the General Business Terms for DNB Markets and information about the terms is available at For requests regarding the General Business Terms of the Singapore Branch of DNB Bank ASA, please contact Information about the DNB Group can be found at DNB Markets is a member of The Norwegian Securities Dealers Association, which has issued recommendations and market standards for securities companies. The Association's Internet address where the recommendations and market standards can be found is: This report is not an offer to buy or sell any security or other financial instrument or to participate in any investment strategy. No liability whatsoever is accepted for any direct or indirect (including consequential) loss or expense arising from the use of this report. Distribution of research reports is in certain jurisdictions restricted by law. Persons in possession of this report should seek further guidance regarding such restrictions before distributing this report. Please contact DNB Markets at ( ) for further information and inquiries regarding this report, including an overview on all recommendations from DNB Markets over the last 12 Months according to Market Abuse Regulations. Additional information for clients in Singapore The report has been distributed by the Singapore Branch of DNB Bank ASA. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should seek advice from a financial adviser regarding the suitability of any product referred to in the report, taking into account your specific financial objectives, financial situation or particular needs before making a commitment to purchase any such product. You have received a copy of the report because you have been classified either as an accredited investor, an expert investor or as an institutional investor, as these terms have been defined under Singapore's Financial Advisers Act (Cap. 110) ("FAA") and/or the Financial Advisers Regulations ("FAR"). The Singapore Branch of DNB Bank ASA is a financial adviser exempt from licensing under the FAA but is otherwise subject to the legal requirements of the FAA and of the FAR. By virtue of your status as an accredited investor or as an expert investor, the Singapore Branch of DNB Bank ASA is, in respect of certain of its dealings with you or services rendered to you, exempt from having to comply with certain regulatory requirements of the FAA and FAR, including without limitation, sections 25, 27 and 36 of the FAA. Section 25 of the FAA requires a financial adviser to disclose material information concerning designated investment products which are recommended by the financial adviser to you as the client. Section 27 of the FAA requires a financial adviser to have a reasonable basis for making investment recommendations to you as the client. Section 36 of the FAA requires a financial adviser to include, within any circular or written communications in which he makes recommendations concerning securities, a statement of the nature of any interest which the financial adviser (and any person connected or associated with the financial adviser) might have in the securities. Please contact the Singapore branch of DNB Bank ASA at in respect of any matters arising from, or in connection with, the report. The report is intended for and is to be circulated only to persons who are classified as an accredited investor, an expert investor or an institutional investor. If you are not an accredited investor, an expert investor or an institutional investor, please contact the Singapore Branch of DNB Bank ASA at We, the DNB group, our associates, officers and/or employees may have interests in any products referred to in the report by acting in various roles including as distributor, holder of principal positions, adviser or lender. We, the DNB group, our associates, officers and/or employees may receive fees, brokerage or commissions for acting in those capacities. In addition, we, the DNB group, our associates, officers and/or employees may buy or sell products as principal or agent and may effect transactions which are not consistent with the information set out in the report. In the United States Each research analyst named on the front page of this research report, or at the beginning of any subsection hereof, hereby certifies that (i) the views expressed in this report accurately reflect that research analyst s personal views about the company and the securities that are the subject of this report; and (ii) no part of the research analyst s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in this report. The research analyst(s) named on this report are foreign research analysts as defined by FINRA Rule The only affiliate contributing to this research report is DNB Bank through its DNB Markets division ( DNB Markets/DNB Bank ); the foreign research analysts employed by DNB Markets/DNB Bank are named on the first page; the foreign research analysts are not registered/qualified as research analysts with FINRA; foreign research analysts are not associated persons of DNB Markets, Inc. and therefore are not subject to the restrictions set forth in FINRA Rules 2241 and 2242 regarding restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. This is a Third Party Research Report as defined by FINRA Rules 2241 and Any material conflict of interest that can reasonably be expected to have influenced the choice of DNB Markets/DNB Bank as a research provider or the subject company of a DNB Markets/DNB Bank research report, including the disclosures required by FINRA Rules 2241 and 2242 can be found above. This report is being furnished solely to Major U.S. Institutional Investors within the meaning of Rule 15a-6 under the U.S. Securities Exchange Act of 1934 and to such other U.S. Institutional Investors as DNB Markets, Inc. may determine. Distribution to non-major U.S. Institutional Investors will be made only by DNB Markets, Inc., a separately incorporated subsidiary of DNB Bank that is a U.S. broker-dealer and a member of the Financial Industry Regulatory Authority ( FINRA ) and the Securities Investor Protection Corporation ( SIPC ). Any U.S. recipient of this report seeking to obtain additional information or to effect any transaction in any security discussed herein or any related instrument or investment should contact DNB Markets, Inc., 200 Park Avenue, New York,NY , telephone number In Canada The Report has been distributed in reliance on the International Dealer Exemption pursuant to NI subsection 8.18(2) and subsection 8.18(4)(b). Please be advised that: 1. DNB Bank ASA (DNB Markets) and DNB Markets, Inc. are not registered as a dealer in the local jurisdiction to make the trade. We provide our services in Canada as an exempt international dealer. 2. The jurisdiction of DNB Bank ASA (DNB Markets) and DNB Markets, Inc.'s head office is Norway. 3. There may be difficulty enforcing legal rights against DNB Bank ASA (DNB Markets) and DNB Markets, Inc. because all or substantially all of their assets may be situated outside of Canada. 4. The name and address of the agent for service of process for DNB Bank ASA (DNB Markets) and DNB Markets, Inc. in the local jurisdiction is: Alberta: Blake, Cassels & Graydon LLP, 855-2nd Street S.W., Suite 3500, Bankers Hall East Tower, Calgary, AB T2P 4J8. British Columbia: Blakes Vancouver Services Inc., 595 Burrard Street, P.O. Box 49314, Suite 2600, Three Bentall Centre, Vancouver, BC V7X 1L3. Manitoba: Aikins, MacAulay & Thorvaldson LLP, 30th Floor, Commodity Exchange Tower, 360 Main Street, Winnipeg, MB R3C 4G1. New Brunswick: Stewart McKelvey, Suite 1000, Brunswick House, 44 Chipman Hill, PO Box 7289, Station A, Saint John, NB E2L 2A9. Newfoundland and Labrador: Stewart McKelvey, Suite 1100, Cabot Place, 100 New Gower Street, P.O. Box 5038, St. John's, NL A1C 5V3. Nova Scotia: Stewart McKelvey, Purdy's Wharf Tower One, 1959 Upper Water Street, Suite 900, P.O. Box 997, Halifax, NS B3J 2X2. Northwest Territories: Gerald Stang, Suite 201, Street, Yellowknife, NT X1A 1P8. Nunavut: Field LLP, P.O. Box 1779, Building 1088C, Iqaluit, NU X0A 0H0. Ontario: Blakes Extra-Provincial Services Inc., Suite 4000, 199 Bay Street, Toronto, ON M5L 1A9. Prince Edward Island: Stewart McKelvey, 65 Grafton Street, Charlottetown, PE C1A 1K8. Québec: Services Blakes Québec Inc., 600 de Maisonneuve Boulevard Ouest, Suite 2200, Tour KPMG, Montréal, QC H3A 3J2. Saskatchewan: MacPherson, Leslie & Tyerman LLP, 1500 Continental Bank Building, 1874 Scarth Street, Regina, SK S4P 4E9. Yukon: Grant Macdonald, Macdonald & Company, Suite 200, Financial Plaza, 204 Lambert Street, Whitehorse, YK Y1A 3T2. In Brazil The analyst or any close associates do not hold nor do they have any direct/indirect involvement in the acquisition, sale, or intermediation of the securities discussed herein. Any financial interests, not disclosed above, that the analyst or any close associates holds in the issuer discussed in the report is limited to investment funds that do not mainly invest in the issuer or industry discussed in the report and the management of which these persons cannot influence. 17

KONGSBERG GRUPPEN Significant losses in KM BUY TP: NOK168

KONGSBERG GRUPPEN Significant losses in KM BUY TP: NOK168 EQUITY RESEARCH 28 October 2016 Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q3 first take KONGSBERG GRUPPEN Significant losses in KM Our initial take on the Q3 results

More information

CHR. HANSEN FC&E margin disappointment SELL TP: DKK490

CHR. HANSEN FC&E margin disappointment SELL TP: DKK490 EQUITY RESEARCH 12 January 2018 Research report prepared by DNB Markets, a division of DNB Bank ASA Materials Q1 2017/18 news flash This report was completed and disseminated at 8:33 CET on 12 January

More information

KONGSBERG GRUPPEN Weak in KM, strong in KDS BUY TP: NOK160

KONGSBERG GRUPPEN Weak in KM, strong in KDS BUY TP: NOK160 EQUITY RESEARCH 8 February 2017 Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q4 news flash KONGSBERG GRUPPEN Weak in KM, strong in KDS Our initial take on Q4 is slightly

More information

ORKLA Organic growth in BCG continues HOLD TP: NOK79.0

ORKLA Organic growth in BCG continues HOLD TP: NOK79.0 EQUITY RESEARCH 9 May 2017 Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q1 news flash ORKLA Organic growth in BCG continues We consider this a slightly positive report

More information

CARGOTEC CMD comments HOLD TP: EUR52.0

CARGOTEC CMD comments HOLD TP: EUR52.0 EQUITY RESEARCH 2017 Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Update 12 September CARGOTEC CMD comments Cargotec's new financial targets were updated last week, ahead

More information

STORA ENSO Oulu one-off ruined a good quarter HOLD TP: EUR12.2

STORA ENSO Oulu one-off ruined a good quarter HOLD TP: EUR12.2 EQUITY RESEARCH 26 July 2017 Research report prepared by DNB Markets, a division of DNB Bank ASA Materials Q2 news comment STORA ENSO Oulu one-off ruined a good quarter Stora Enso s Q2 was a small disappointment

More information

SELVAAG BOLIG No climate change HOLD TP: NOK32.0

SELVAAG BOLIG No climate change HOLD TP: NOK32.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q3 results review This report was completed and disseminated at 20:26 CET on 0 SELVAAG BOLIG No climate change

More information

SELL TP: NOK3.00. NORSKE SKOG Signs of deleveraging

SELL TP: NOK3.00. NORSKE SKOG Signs of deleveraging EQUITY RESEARCH Materials Bulletin NORSKE SKOG Signs of deleveraging Norske Skog has announced an offer of EUR250m senior secured notes primarily to facilitate a debt exchange for existing bonds, maturing

More information

OFFSHORE DRILLING Four Sete rigs to be continued

OFFSHORE DRILLING Four Sete rigs to be continued EQUITY RESEARCH 1 March 2018 Research report prepared by DNB Markets, a division of DNB Bank ASA This report was completed and disseminated at 17:01 CET on OFFSHORE DRILLING Four Sete rigs to be continued

More information

WALLENIUS WILHELMSEN LOGISTICS Consensus is catching up BUY TP: NOK67.0

WALLENIUS WILHELMSEN LOGISTICS Consensus is catching up BUY TP: NOK67.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Bulletin This report was completed and disseminated at 21:45 CET on 0 WALLENIUS WILHELMSEN LOGISTICS Consensus

More information

WALLENIUS WILHELMSEN LOGISTICS From spare parts to order intake BUY TP: NOK50.0

WALLENIUS WILHELMSEN LOGISTICS From spare parts to order intake BUY TP: NOK50.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q1 preview WALLENIUS WILHELMSEN LOGISTICS From spare parts to order intake We are 3% above Q1e consensus

More information

BETSSON Looking past FX and sports results BUY TP: SEK110

BETSSON Looking past FX and sports results BUY TP: SEK110 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Consumer Discretionary Q1 results review BETSSON Looking past FX and sports results Betsson is struggling with near-term

More information

Nibe Industrier US residential recovery on horizon HOLD TP: SEK82.0

Nibe Industrier US residential recovery on horizon HOLD TP: SEK82.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Bulletin This report was completed and disseminated at 7:02 CET on Nibe Industrier US residential recovery

More information

ODFJELL Rotterdam needs to deliver BUY TP: NOK39.0

ODFJELL Rotterdam needs to deliver BUY TP: NOK39.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q4 results review ODFJELL Rotterdam needs to deliver We reiterate our BUY recommendation but have lowered

More information

BETSSON Dutch risks versus earnings upside BUY TP: SEK110

BETSSON Dutch risks versus earnings upside BUY TP: SEK110 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Consumer Discretionary Q2 preview BETSSON Dutch risks versus earnings upside We expect a Q2 organic growth improvement

More information

STOREBRAND Solvency beat again BUY TP: NOK95.0

STOREBRAND Solvency beat again BUY TP: NOK95.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Q2 results review This report was completed and disseminated at 19:27 CET on STOREBRAND Solvency beat again

More information

ODFJELL DRILLING M&A potential BUY TP: NOK24.0

ODFJELL DRILLING M&A potential BUY TP: NOK24.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Energy Update ODFJELL DRILLING M&A potential Following Transocean s acquisition of Songa Offshore, we consider Odfjell

More information

WILLIAM DEMANT HOLDING 2017e to be front-end loaded SELL TP: DKK125

WILLIAM DEMANT HOLDING 2017e to be front-end loaded SELL TP: DKK125 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Health Care Update WILLIAM DEMANT HOLDING 2017e to be front-end loaded William Demant is due to publish its Q1 trading

More information

SPAREBANKEN MØRE Steady banking HOLD TP: NOK245

SPAREBANKEN MØRE Steady banking HOLD TP: NOK245 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Q1 results review SPAREBANKEN MØRE Steady banking The Q1 ROE was 10.1%, with EPS 3% above consensus, primarily

More information

PETROLEUM GEO-SERVICES Don t poke the sleeping bear SELL TP: NOK13.0

PETROLEUM GEO-SERVICES Don t poke the sleeping bear SELL TP: NOK13.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Energy Q2 results review PETROLEUM GEO-SERVICES Don t poke the sleeping bear PGS reported a strong Q2; however, the combination

More information

SAIPEM All eyes on Kaombo SELL TP: EUR3.10

SAIPEM All eyes on Kaombo SELL TP: EUR3.10 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Energy Q2 2017 preview SAIPEM All eyes on Kaombo We reiterate SELL ahead of the Q2 report, due on 25 July at 07:00 CET.

More information

ALK-ABELLO Accelerated launch of ODACTRA BUY TP: DKK1200

ALK-ABELLO Accelerated launch of ODACTRA BUY TP: DKK1200 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Health Care Company update ALK-ABELLO Accelerated launch of ODACTRA ALK-Abello has announced that the FDA has completed

More information

ORIFLAME Operations, Q2 sales and Turkey SELL TP: SEK270

ORIFLAME Operations, Q2 sales and Turkey SELL TP: SEK270 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Consumer Staples preview ORIFLAME Operations, sales and Turkey Oriflame s results are due at 07: CET on 10 May. We expect

More information

METSA BOARD EBIT pinched by latex BUY TP: EUR7.80

METSA BOARD EBIT pinched by latex BUY TP: EUR7.80 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Materials Q1 result review METSA BOARD EBIT pinched by latex Metsa Board is on course for a slightly soft H1 due to some

More information

GJENSIDIGE FORSIKRING Set for solid Q2 HOLD TP: NOK150

GJENSIDIGE FORSIKRING Set for solid Q2 HOLD TP: NOK150 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Bulletin GJENSIDIGE FORSIKRING Set for solid Q2 We expect Gjensidige to report a solid Q2 EPS of NOK2.5 (results

More information

AF GRUPPEN SELL TP: NOK100. Margins save Q3; valuation still a risk

AF GRUPPEN SELL TP: NOK100. Margins save Q3; valuation still a risk EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q3 results review AF GRUPPEN Margins save Q3; valuation still a risk Q3 adj. EPS was 18% above our forecast

More information

SPAREBANK 1 ØSTLANDET Solid quarter with 12% ROE BUY TP: NOK100

SPAREBANK 1 ØSTLANDET Solid quarter with 12% ROE BUY TP: NOK100 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Q3 results review This report was completed and disseminated at 19:18 CET on SPAREBANK 1 ØSTLANDET Solid quarter

More information

PEAB Normalized EBIT margins should lead to an attractive P/E BUY TP: SEK80.0

PEAB Normalized EBIT margins should lead to an attractive P/E BUY TP: SEK80.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q3 results review PEAB Normalized EBIT margins should lead to an attractive P/E Peab s Q3 reported results

More information

VITROLIFE CMD takeaways BUY TP: SEK570

VITROLIFE CMD takeaways BUY TP: SEK570 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Health Care Update VITROLIFE CMD takeaways At Vitrolife s CMD yesterday, focus was very much on Time-lapse and the recently

More information

ORIFLAME Beauty with beastly valuation SELL TP: SEK211

ORIFLAME Beauty with beastly valuation SELL TP: SEK211 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Consumer Staples Q3 Preview ORIFLAME Beauty with beastly valuation The Q3 results are due on 11 November at 07:15 CET.

More information

NIBE INDUSTRIER Long-term gain, short-term uncertainty HOLD TP: SEK80.0

NIBE INDUSTRIER Long-term gain, short-term uncertainty HOLD TP: SEK80.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Bulletin NIBE INDUSTRIER Long-term gain, short-term uncertainty We like the long-term growth story in NIBE

More information

FRED OLSEN ENERGY No equity value according to peer group valuation SELL TP: NOK5.00

FRED OLSEN ENERGY No equity value according to peer group valuation SELL TP: NOK5.00 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Energy Update FRED OLSEN ENERGY No equity value according to peer group valuation Our asset-based peer group valuation

More information

SOLON EIENDOM Less per unit in Q3 HOLD TP: NOK18.5

SOLON EIENDOM Less per unit in Q3 HOLD TP: NOK18.5 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q3 results review This report was completed and disseminated at 20:38 CET on 0 SOLON EIENDOM Less per unit

More information

ORIFLAME Focus on Asia & Turkey SELL TP: SEK331

ORIFLAME Focus on Asia & Turkey SELL TP: SEK331 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Consumer Staples Q4 preview This report was completed and disseminated at 6:48 CET on 0 ORIFLAME Focus on Asia & Turkey

More information

STOREBRAND A quarter of tailwinds BUY TP: NOK80.0

STOREBRAND A quarter of tailwinds BUY TP: NOK80.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Q2 preview STOREBRAND A quarter of tailwinds We expect a Q2 Solvency II ratio of 152%, up 5%-points QOQ (results

More information

LATOUR Robust Q1 for Industrial operations HOLD TP: SEK402

LATOUR Robust Q1 for Industrial operations HOLD TP: SEK402 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Result LATOUR Robust Q1 for Industrial operations s industrial operations reported Q1 organic growth of 11%.

More information

Weak quarter, but guidance reiterated

Weak quarter, but guidance reiterated Q1 2011 Initial comment BUY Weak quarter, but guidance reiterated 19.05.2011 vs OSEBX (12m) 14 12 10 8 6 4 2 May Jul Sep Nov Jan Mar May OSEBX (Rebased) Share price and target Price NOK 12.35 Price target

More information

LATOUR Cautious optimism HOLD TP: SEK360

LATOUR Cautious optimism HOLD TP: SEK360 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Results review LATOUR Cautious optimism The Q4 NAV was in line with estimates, and the proposed DPS of SEK8

More information

GJENSIDIGE FORSIKRING Set for strong Q3 HOLD TP: NOK150

GJENSIDIGE FORSIKRING Set for strong Q3 HOLD TP: NOK150 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Financials Q3 preview GJENSIDIGE FORSIKRING Set for strong Q3 We expect Gjensidige to report solid Q3 results, driven

More information

SELVAAG BOLIG Weak intake lowers forecasts HOLD TP: NOK38.0

SELVAAG BOLIG Weak intake lowers forecasts HOLD TP: NOK38.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q1 preview SELVAAG BOLIG Weak intake lowers forecasts The market inventory of homes for sale in Oslo continues

More information

SELVAAG BOLIG Super-profits as NAV materialises HOLD TP: NOK43.0

SELVAAG BOLIG Super-profits as NAV materialises HOLD TP: NOK43.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q4 results review SELVAAG BOLIG Super-profits as NAV materialises Selvaag Bolig beat Q4 forecasts, having

More information

VEIDEKKE Lowered EPS on housing outlook BUY TP: NOK135

VEIDEKKE Lowered EPS on housing outlook BUY TP: NOK135 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q4 preview VEIDEKKE Lowered EPS on housing outlook We are in line with consensus ahead of Veidekke s Q4 result

More information

GETINGE Continued high uncertainty SELL TP: SEK165

GETINGE Continued high uncertainty SELL TP: SEK165 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Health Care Result GETINGE Continued high uncertainty Getinge reported Q3 earnings basically in line with topline and

More information

BORREGAARD Margin debacle HOLD TP: NOK85.0

BORREGAARD Margin debacle HOLD TP: NOK85.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Materials Q3 results review This report was completed and disseminated at 6:45 CET on BORREGAARD Margin debacle The key

More information

A. P. MØLLER MÆRSK Guidance raise seems inevitable BUY TP: DKK13250

A. P. MØLLER MÆRSK Guidance raise seems inevitable BUY TP: DKK13250 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Preview A. P. MØLLER MÆRSK Guidance raise seems inevitable We reiterate our BUY recommendation and DKK13,250

More information

ORKLA Pick n mix HOLD TP: NOK79.0

ORKLA Pick n mix HOLD TP: NOK79.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q4 results review ORKLA Pick n mix We remain enthusiastic about Orkla s long-term growth potential; we expect

More information

OFFSHORE DRILLING Perfect storm brewing in Brazil

OFFSHORE DRILLING Perfect storm brewing in Brazil EQUITY RESEARCH OFFSHORE DRILLING Perfect storm brewing in Brazil The concurrent timing of the Petrobras 2400m tender, the Petrobras 2015 extensions and a weakening in the global deepwater market is set

More information

IN THE MATTER OF THE SECURITIES ACT, R.S.N.W.T. 1988, ch. S-5, AS AMENDED. IN THE MATTER OF Certain Exemptions for Capital Accumulation Plans

IN THE MATTER OF THE SECURITIES ACT, R.S.N.W.T. 1988, ch. S-5, AS AMENDED. IN THE MATTER OF Certain Exemptions for Capital Accumulation Plans IN THE MATTER OF THE SECURITIES ACT, R.S.N.W.T. 1988, ch. S-5, AS AMENDED - and - IN THE MATTER OF Certain Exemptions for Capital Accumulation Plans BLANKET ORDER NO. 6 WHEREAS the Joint Forum of Financial

More information

Form F2 Change or Surrender of Individual Categories (section 2.2(2), 2.4, 2.6(2) or 4.1(4))

Form F2 Change or Surrender of Individual Categories (section 2.2(2), 2.4, 2.6(2) or 4.1(4)) Form 33-109F2 Change or Surrender of Individual Categories (section 2.2(2), 2.4, 2.6(2) or 4.1(4)) GENERAL INSTRUCTIONS Complete and submit this form to notify the relevant regulator(s) or, in Québec,

More information

ODFJELL About to enter harvest mode BUY TP: NOK46.0

ODFJELL About to enter harvest mode BUY TP: NOK46.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Company update ODFJELL About to enter harvest mode Odfjell is trading at 0.5x its past 10-year earnings multiple,

More information

HUMANA Extending the Nordic lead BUY TP: SEK90.0

HUMANA Extending the Nordic lead BUY TP: SEK90.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Health Care Update HUMANA Extending the Nordic lead Humana s deal capacity gains further credentials with the value-enhancing

More information

Yara International ASA 2017 fourth quarter results. 8 February 2018

Yara International ASA 2017 fourth quarter results. 8 February 2018 Yara International ASA 217 fourth quarter results 8 February 218 Safe operations is our first priority 4.5 4. TRI (Total recordable injuries 12-month rolling) 1 3.5 3. 2.5 2. 1.5 Jan Feb Mar Apr May Jun

More information

GENER8 MARITIME Still too early HOLD TP: USD4.40

GENER8 MARITIME Still too early HOLD TP: USD4.40 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Energy Q3 results review GENER8 MARITIME Still too early We reiterate our HOLD recommendation and have cut our target

More information

Unofficial consolidation April 1, 2017 FORM F1. Insider Profile

Unofficial consolidation April 1, 2017 FORM F1. Insider Profile Unofficial consolidation April 1, 2017 FORM 55-102F1 Insider Profile An insider profile filed in SEDI format shall contain the information prescribed below. The information shall be entered using the online

More information

COMPANION POLICY CP REGISTRATION INFORMATION TABLE OF CONTENTS

COMPANION POLICY CP REGISTRATION INFORMATION TABLE OF CONTENTS This document is an unofficial consolidation of all amendments to Companion Policy to National Instrument 33-109 Registration Information, effective as of December 4, 2017. This document is for reference

More information

Amendments to National Instrument Registration Information

Amendments to National Instrument Registration Information Amendments to National Instrument 33-109 Registration Information 1. National Instrument 33-109 Registration Information is amended by this Instrument. 2. The definition of NI 31-103 in section 1.1 is

More information

FORM F7 REINSTATEMENT OF REGISTERED INDIVIDUALS AND PERMITTED INDIVIDUALS (sections 2.3 and 2.5(2))

FORM F7 REINSTATEMENT OF REGISTERED INDIVIDUALS AND PERMITTED INDIVIDUALS (sections 2.3 and 2.5(2)) FORM 33-109F7 REINSTATEMENT OF REGISTERED INDIVIDUALS AND PERMITTED INDIVIDUALS (sections 2.3 and 2.5(2)) GENERAL INSTRUCTIONS Complete and submit this form to the relevant regulator(s) or in Québec, the

More information

Statement of Policies respecting Conflicts of Interest

Statement of Policies respecting Conflicts of Interest Statement of Policies respecting Conflicts of Interest Investments inc. regulation applicable in Canada requires dealers and advisers to comply with certain rules in relation to conflicts of interest,

More information

Form F1 REPORT OF EXEMPT DISTRIBUTION

Form F1 REPORT OF EXEMPT DISTRIBUTION Form 45-106F1 REPORT OF EXEMPT DISTRIBUTION This is the form required under section 6.1 of National Instrument 45-106 for a report of exempt distribution. Issuer/underwriter information Item 1: State the

More information

FORM F1 REPORT OF EXEMPT DISTRIBUTION

FORM F1 REPORT OF EXEMPT DISTRIBUTION FORM 45-106F1 REPORT OF EXEMPT DISTRIBUTION This is the form required under section 6.1 of National Instrument 45-106 for a report of exempt distribution. Issuer information Item 1: State the full name

More information

FORM F7 REINSTATEMENT OF REGISTERED INDIVIDUALS AND PERMITTED INDIVIDUALS (sections 2.3 and 2.5(2))

FORM F7 REINSTATEMENT OF REGISTERED INDIVIDUALS AND PERMITTED INDIVIDUALS (sections 2.3 and 2.5(2)) FORM 33-109F7 REINSTATEMENT OF REGISTERED INDIVIDUALS AND PERMITTED INDIVIDUALS (sections 2.3 and 2.5(2)) GENERAL INSTRUCTIONS Complete and submit this form to the relevant regulator(s) or, in Québec,

More information

Quiet quarter, attractive valuation

Quiet quarter, attractive valuation Result Preview 15-Apr-13 Aker Sector: Industrial Conglomerates Recommendation: BUY (unchanged) Target price (NOK): 260 (unchanged) Analyst: Terje Mauer Tel: +47 22 01 63 24 E-mail: terje.mauer@platou.com

More information

ContextVision. Expecting solid results and awaiting progress update on research program

ContextVision. Expecting solid results and awaiting progress update on research program 1Q17 Preview (report due April 27 th ) April 24 th 2017 Share price: NOK 61.75 Target: NOK 100.00 (unchanged) Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV

More information

AMENDMENTS TO NATIONAL INSTRUMENT REGISTRATION INFORMATION

AMENDMENTS TO NATIONAL INSTRUMENT REGISTRATION INFORMATION AMENDMENTS TO NATIONAL INSTRUMENT 33-109 REGISTRATION INFORMATION 1. National Instrument 33-109 Registration Information is amended by this Instrument. 2. Section 1.1 is amended by (a) adding the following

More information

WILH. WILHELMSEN ASA Both main markets at cyclical low BUY TP: NOK50.0

WILH. WILHELMSEN ASA Both main markets at cyclical low BUY TP: NOK50.0 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q4 results review WILH. WILHELMSEN ASA Both main markets at cyclical low We reiterate our BUY recommendation

More information

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium. August 18 th 2014 Share price: NOK 21.70 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV:NO Market Cap (NOKm) 167.9 Net debt (NOKm) -28.6 EV

More information

Form F1 Report of Exempt Distribution

Form F1 Report of Exempt Distribution Form 45-106F1 Report of Exempt Distribution A. General Instructions 1. Filing instructions An issuer or underwriter that is required to file a report of exempt distribution and pay the applicable fee must

More information

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24. 3Q14 Results analysis November 5 th 2014 Share price: NOK 22.00 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg ContextVision is a market making client of Norne Securities

More information

Registration Exemption for Trades in Connection with Certain Prospectus-Exempt Distributions

Registration Exemption for Trades in Connection with Certain Prospectus-Exempt Distributions . IN THE MATTER OF THE SECURITIES ACT, S.N.W.T. 2008, c. 10, AS AMENDED - and - Registration Exemption for Trades in Connection with Certain Prospectus-Exempt Distributions BLANKET ORDER 32-501 WHEREAS

More information

Yara International ASA 2017 third quarter results. 19 October 2017

Yara International ASA 2017 third quarter results. 19 October 2017 Yara International ASA 217 third quarter results 19 October 217 Safe operations is our first priority 4.5 4. TRI (Total recordable injuries 12-month rolling) 1 3.5 3. 2.5 2. 1.5 Jan '16 Feb Mar Apr May

More information

NORDIC NON-LIFE Weather and financial market chills

NORDIC NON-LIFE Weather and financial market chills EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA This report was completed and disseminated at 7:01 CET on 0 NORDIC NON-LIFE Weather and financial market chills We expect

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

MULTILATERAL INSTRUMENT

MULTILATERAL INSTRUMENT Chapter 5 Rules and Policies 5.1.1 Multilateral Instrument 33-109, Registration Information MULTILATERAL INSTRUMENT 33-109 REGISTRATION INFORMATION TABLE OF CONTENTS PART TITLE PART 1 DEFINITIONS 1.1 Definitions

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

Yara International ASA Fourth quarter results 2014

Yara International ASA Fourth quarter results 2014 1 Yara International ASA Fourth quarter results 2014 11 February 2015 2 Summary fourth quarter Strong result driven by higher margins Margins benefit from lower European gas prices and stronger US dollar

More information

LG International (001120) Poor 3Q expected to be just a blip WHAT S THE STORY? SUMMARY OF 3Q RESULTS

LG International (001120) Poor 3Q expected to be just a blip WHAT S THE STORY? SUMMARY OF 3Q RESULTS Company Update LG International (112) Poor 3Q expected to be just a blip Jaeseung Baek Analyst jaeseung.baek@samsung.com 822 22 7794 LG International (LGI) yesterday reported that its consolidated sales

More information

Yara International ASA First Quarter results 2013

Yara International ASA First Quarter results 2013 Yara International ASA First Quarter results 213 22 April 213 1 Summary first quarter Strong results with stable margins Strong cash flow Fertilizer deliveries close to last year despite late spring Record

More information

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40%

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40% Vol mn RSI10 SAFCO Petrochemicals Industrial SAFCO AB: Saudi Arabia US$7.22bn 40% US$5.60mn Market cap Free float Avg. daily volume Target price 62.00-2.6% over current Current price 63.70 as at 8/5/2018

More information

GENERAL ORDER REGISTRATION EXEMTION FOR TRADES IN CONNECTION WITH CERTAIN PROSPECTUS EXEMPT DISTRIBUTIONS

GENERAL ORDER REGISTRATION EXEMTION FOR TRADES IN CONNECTION WITH CERTAIN PROSPECTUS EXEMPT DISTRIBUTIONS Saskatchewan Saskatchewan Financial Services Commission Securities Division GENERAL ORDER 45-918 REGISTRATION EXEMTION FOR TRADES IN CONNECTION WITH CERTAIN PROSPECTUS EXEMPT DISTRIBUTIONS IN THE MATTER

More information

British Columbia Securities Commission. BC Instrument

British Columbia Securities Commission. BC Instrument British Columbia Securities Commission BC Instrument 32-513 Registration Exemption for Trades in Connection with Certain Prospectus-Exempt Distributions The British Columbia Securities Commission, considering

More information

Mackenzie's Canadian Federal / Provincial Marginal Tax Rates

Mackenzie's Canadian Federal / Provincial Marginal Tax Rates Mackenzie's Federal / Provincial Marginal Tax Rates Current as of: July 1, 2012 Quick Links by Province AB NS QC BC NT SK MB NU YT NB ON NL PE How To Use These Tables: Marginal Tax Rates calculate the

More information

The Saskatchewan Gazette

The Saskatchewan Gazette THE SASKATCHEWAN GAZETTE, FEBRUARY 27, 2015 113 The Saskatchewan Gazette PUBLISHED WEEKLY BY AUTHORITY OF THE QUEEN S PRINTER/Publiée chaque semaine sous l autorité de l Imprimeur de la Reine PART II/PARTIE

More information

TVS Motors. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709

More information

GENCO SHIPPING & TRADING Poised for opportunities BUY TP: USD15.4

GENCO SHIPPING & TRADING Poised for opportunities BUY TP: USD15.4 EQUITY RESEARCH Research report prepared by DNB Markets, a division of DNB Bank ASA Industrials Q2 results review GENCO SHIPPING & TRADING Poised for opportunities Genco Shipping & Trading has completed

More information

Exempt market securities. The complete overview.

Exempt market securities. The complete overview. Exempt market securities. The complete overview. Commission des valeurs mobilières du Québec April 1999 All rights reserved La version française de cette brochure est disponible sur demande. OVERVIEW Exempt

More information

MULTILATERAL INSTRUMENT RESALE OF SECURITIES TABLE OF CONTENTS

MULTILATERAL INSTRUMENT RESALE OF SECURITIES TABLE OF CONTENTS PART 1 DEFINITIONS 1.1 Definitions MULTILATERAL INSTRUMENT 45-102 RESALE OF SECURITIES TABLE OF CONTENTS PART 2 FIRST TRADES 2.1 Application 2.2 Removal of Resale Provisions 2.3 Section 2.5 Applies 2.4

More information

Yara International ASA. 21 October 2011

Yara International ASA. 21 October 2011 Yara International ASA Third quarter results 211 21 October 211 1 Summary third quarter Strong results driven by improved margins Strong demand outside Europe, satisfactory sales in Europe Sluiskil urea

More information

Yara International ASA Third Quarter results 2013

Yara International ASA Third Quarter results 2013 Yara International ASA Third Quarter results 213 18 October 213 IR-Date: 213-1-18 1 Summary third quarter Strong results despite weaker commodity fertilizer markets 17% increase in deliveries including

More information

Annex C. Amendments to National Instrument Prospectus Exemptions

Annex C. Amendments to National Instrument Prospectus Exemptions Annex C Amendments to National Instrument 45-106 Prospectus Exemptions 1. National Instrument 45-106 Prospectus Exemptions is amended by this Instrument. 2. Section 6.2 is amended by adding the following

More information

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin.

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin. DOL (T) $110.88 Stock Rating: Outperform (Unchanged) Target: $122.00 (Was $113.00) Risk Rating: Below Average (Unchanged) Est. Total Return: 10.4% Stock Data: 52-week High-Low (Canada) Bloomberg $104.94

More information

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630 1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton

More information

Economic outlook: Manitoba in the middle

Economic outlook: Manitoba in the middle Economic outlook: Manitoba in the middle May 17, 2016 Douglas Porter, CFA Chief Economist, BMO Financial Group douglas.porter@bmo.com 416-359-4887 Please refer to the next page for Important Disclosures

More information

NATIONAL INSTRUMENT REGISTRATION INFORMATION

NATIONAL INSTRUMENT REGISTRATION INFORMATION This document is an unofficial consolidation of all amendments to National Instrument 33-109 Registration Information (NI 33-109) and its Companion Policy, effective as of January 11, 2015. This document

More information

Mahindra & Mahindra. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty

More information

Opus Group. Equity Research. US could be supportive. Buy (Neutral) Target price: SEK 9.00 (10.0) Share price: SEK August, 2015.

Opus Group. Equity Research. US could be supportive. Buy (Neutral) Target price: SEK 9.00 (10.0) Share price: SEK August, 2015. Equity Research 21 August, 20 Opus Group US could be supportive Q2 EBITDA slightly better than expected US platform in place Relative pricing in favor Q2 figures The Q2 EBITDA of SEK 94m (88) was 2-3%

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Misses estimates; Higher costs dims hope for earnings recovery February 13, 2017 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Rating Reduce Price Rs325 Target Price Rs320 Implied Upside 1.5%

More information

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS. Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully

More information

Ahluwalia Contracts (India)

Ahluwalia Contracts (India) May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information

3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%)

3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%) European Equity Research ACCIONA Facing a Good 2017E Spain Electricity November 7, 2016 (07:15 CET) BUY CURRENT PRICE: 69.01 TARGET PRICE: 82.40 ANA released 9M16 results on Nov 4 and we have adjusted

More information